Few people with heart failure take guideline-recommended drug

Heart failure patients who could possibly benefit from a newer class of drug to lower their heart rate were more likely to take the medication if it was prescribed before hospital discharge rather than in a follow-up doctor’s visit, according to preliminary research presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions in Arlington, Virginia.

The study team included several researchers from CONNECT-HF and you can read more about the results here.